{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:04:17Z","timestamp":1773281057002,"version":"3.50.1"},"reference-count":22,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Although anti-M\u00fcllerian hormone (AMH) is a strong biomarker of ovarian reserve and oocyte pools, it is unknown whether high AMH levels can be a reliable predictor of oocyte quality, ovulation, and embryo quality. We aimed to determine whether there is any AMH threshold value that can be used to predict treatment success in women with clomiphene citrate (CC) resistance or failure in polycystic ovary syndrome (PCOS). Methods: This retrospective cohort study included 93 infertile women with PCOS who had been previously diagnosed with CC failure or CC resistance between May 2017 and June 2018. Prior to treatment, AMH concentration was measured in all women. The participants were divided into 2 groups according to their conception after ovulation induction (OI) and intrauterine insemination (IUI). At the end of a one-year period, the medical files were assessed retrospectively. Those with and without pregnancy were compared in terms of treatment protocols, infertility periods, laboratory parameters and AMH levels. Results: Clinical and biochemical characteristics of 36 pregnant women were compared with those of 57 non-pregnant women. The results showed that the pregnant group had significantly shorter infertility periods and longer ovarian stimulations than the non-pregnant group (p &lt; 0.05). Serum AMH levels &gt; 4.5 ng\/mL can predict OI and IUI outcome in this specific patient population, with a sensitivity of 56% and a specificity of 69%. Multivariate logistic regression analysis showed that only AMH was identified as an independent predictor of pregnancy [OR = 1.151 (95% CI: 1.034\u20131.280), p = 0.010]. Conclusions: Serum AMH may serve as an adjunct predictor of OI and IUI outcomes in infertile women with PCOS who failed to conceive after \u22653 cycles of CC. However, its predictive value appears to be context-dependent and should be interpreted cautiously in clinical practice. Given the distinct clinical characteristics of this patient population, individualized treatment strategies and consideration of earlier alternative therapeutic approaches may be warranted to optimize reproductive outcomes.<\/jats:p>","DOI":"10.3390\/jcm15062138","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T10:43:27Z","timestamp":1773225807000},"page":"2138","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Elevated Serum Anti-M\u00fcllerian Hormone Levels on Ovulation Induction and Intrauterine Insemination Outcomes in Infertile Women with Polycystic Ovary Syndrome After Failure of \u22653 Clomiphene Citrate Cycles"],"prefix":"10.3390","volume":"15","author":[{"given":"Rifat Taner","family":"Aksoy","sequence":"first","affiliation":[{"name":"Department of Reproductive Endocrinology and Infertility, Zekai Tahir Burak Women\u2019s Health Education and Research Hospital, 06230 Ankara, Turkey"},{"name":"Department of Reproductive Endocrinology and Infertility, Ankara City Hospital, University of Health Sciences, 06200 Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulnur","family":"Ozaksit","sequence":"additional","affiliation":[{"name":"Department of Reproductive Endocrinology and Infertility, Zekai Tahir Burak Women\u2019s Health Education and Research Hospital, 06230 Ankara, Turkey"},{"name":"Department of Reproductive Endocrinology and Infertility, Ankara City Hospital, University of Health Sciences, 06200 Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurhan","family":"Guney","sequence":"additional","affiliation":[{"name":"Department of Reproductive Endocrinology and Infertility, Medical Faculty, Balikesir University, 10145 Balikesir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meryem","family":"Kuru Pekcan","sequence":"additional","affiliation":[{"name":"Department of Reproductive Endocrinology and Infertility, Zekai Tahir Burak Women\u2019s Health Education and Research Hospital, 06230 Ankara, Turkey"},{"name":"Department of Reproductive Endocrinology and Infertility, Ankara City Hospital, University of Health Sciences, 06200 Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5739-5689","authenticated-orcid":false,"given":"Aytekin","family":"Tokmak","sequence":"additional","affiliation":[{"name":"Department of Reproductive Endocrinology and Infertility, Zekai Tahir Burak Women\u2019s Health Education and Research Hospital, 06230 Ankara, Turkey"},{"name":"Department of Reproductive Endocrinology and Infertility, Ankara City Hospital, University of Health Sciences, 06200 Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1055\/a-1025-3711","article-title":"Several Circulating Biomarkers for PCOS Diagnosis","volume":"129","author":"Luo","year":"2019","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.mcna.2022.10.004","article-title":"Polycystic Ovarian Syndrome","volume":"107","author":"Shrivastava","year":"2023","journal-title":"Med. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","article-title":"Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies","volume":"35","year":"2020","journal-title":"Mol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coemr.2020.03.001","article-title":"What causes anovulation in polycystic ovary syndrome?","volume":"12","author":"Franks","year":"2020","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rbmo.2016.04.007","article-title":"The role of AMH in the pathophysiology of polycystic ovarian syndrome","volume":"33","author":"Garg","year":"2016","journal-title":"Reprod. Biomed. Online"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/humrep\/deu076","article-title":"The role of AMH in anovulation associated with PCOS: A hypothesis","volume":"29","author":"Homburg","year":"2014","journal-title":"Hum. Reprod."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00404-014-3447-6","article-title":"Predictors of success of laparoscopic ovarian drilling in women with polycystic ovary syndrome: An evidence-based approach","volume":"291","year":"2015","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_8","first-page":"381","article-title":"Ovarian granulosa cell tumor and clomiphene citrate resistance. A case report and review of the literature","volume":"22","author":"Triantafyllidou","year":"2018","journal-title":"Jbra Assist. Reprod."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/humupd\/dmw027","article-title":"Interactions between androgens, FSH, anti-M\u00fcllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary","volume":"22","author":"Dewailly","year":"2016","journal-title":"Hum. Reprod. Updat."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1472-6483(10)60379-3","article-title":"Clinical significance of serum concentration of anti-M\u00fcllerian hormone in obese women with polycystic ovary syndrome","volume":"15","author":"Rizk","year":"2007","journal-title":"Reprod. Biomed. Online"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1210\/jc.2013-2193","article-title":"The predictive value of circulating anti-M\u00fcllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: A prospective observational study","volume":"98","author":"Mahran","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13048-016-0214-2","article-title":"Circulating anti-mullerian hormone as predictor of ovarian response to clomiphene citrate in women with polycystic ovary syndrome","volume":"9","author":"Xi","year":"2016","journal-title":"J. Ovarian Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3904\/kjim.2016.038","article-title":"Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-M\u00fcllerian hormone cutoff value","volume":"32","author":"Song","year":"2017","journal-title":"Korean J. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijgo.2015.09.008","article-title":"Predictors of patient responses to ovulation induction with clomiphene citrate in patients with polycystic ovary syndrome experiencing infertility","volume":"133","author":"Ellakwa","year":"2016","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/09513590.2017.1370644","article-title":"Therapeutic approach for metabolic disorders and infertility in women with PCOS","volume":"34","author":"Morgante","year":"2018","journal-title":"Gynecol. Endocrinol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13048-019-0564-7","article-title":"Changes in serum markers of patients with PCOS during consecutive clomiphene stimulation cycles: A retrospective study","volume":"12","author":"Hager","year":"2019","journal-title":"J. Ovarian Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1093\/humrep\/dep114","article-title":"Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome","volume":"24","author":"Overbeek","year":"2009","journal-title":"Hum. Reprod."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10815-015-0615-y","article-title":"The anti-M\u00fcllerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH","volume":"33","author":"Sacchi","year":"2016","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"8685158","DOI":"10.1155\/2021\/8685158","article-title":"The Role of FSHR SNPs and AMH in Follicular Fluid and Serum in Ovarian Response during COS: A Pilot Study","volume":"2021","author":"Anagnostou","year":"2021","journal-title":"Int. J. Reprod. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","article-title":"Early follicular serum m\u00fcllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles","volume":"77","author":"Seifer","year":"2002","journal-title":"Fertil. Steril."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1477-7827-11-115","article-title":"The influence of circulating anti-M\u00fcllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: A pilot study","volume":"11","author":"Amer","year":"2013","journal-title":"Reprod. Biol. Endocrinol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/6\/2138\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T11:12:44Z","timestamp":1773227564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/6\/2138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["jcm15062138"],"URL":"https:\/\/doi.org\/10.3390\/jcm15062138","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]}}}